Originally posted by AllSeq
View Post
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
-
Comment
-
Originally posted by GenoMax View PostI thought the only default option one had was to deny existence/all knowledge of the "entity" that was subject of a NDA. I was surprised at your admission in that context.
I'm from New Jersey...we bury NDA's in the Meadowlands or under Giants Stadium.
Comment
-
The embargo has been lifted so we can finally talk about the new Ion S5 – it’s basically a streamlined combination of the PGM and Proton made as easy to use as possible for ‘novice users’. See our blog post for more details and then tell us what you think: A useful addition to the NGS market? Too little too late?
Comment
-
Originally posted by GW_OK View PostDoes anyone know reagent costs? All I'm seeing discussed is equipment price.
Comment
-
As far as I can tell, costs are almost the same when comparing PGM-318 vs S5-520 and Proton PI vs S5-540. Correct?
So really what is missing with the S5 is the low-output low-cost option of the PGM-314 and -316. Not sure if that is such a smart idea, since there are labs around that want to run a low throughput sample quickly without waiting for more samples to come in. That has been one of the big plus points for Ion IMHO, plus the extremely well working Ampliseq custom panels......
Comment
-
Originally posted by Xray1 View PostAs far as I can tell, costs are almost the same when comparing PGM-318 vs S5-520 and Proton PI vs S5-540. Correct?
So really what is missing with the S5 is the low-output low-cost option of the PGM-314 and -316. Not sure if that is such a smart idea, since there are labs around that want to run a low throughput sample quickly without waiting for more samples to come in. That has been one of the big plus points for Ion IMHO, plus the extremely well working Ampliseq custom panels......
As far as the quality of sequencing, so far, so good (maybe even a bit better than the PGM).
Comment
Latest Articles
Collapse
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
24 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|
||
Started by seqadmin, 04-10-2024, 10:19 PM
|
0 responses
25 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 10:19 PM
|
||
Started by seqadmin, 04-10-2024, 09:21 AM
|
0 responses
21 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 09:21 AM
|
||
Started by seqadmin, 04-04-2024, 09:00 AM
|
0 responses
52 views
0 likes
|
Last Post
by seqadmin
04-04-2024, 09:00 AM
|
Comment